Ronna E. Dornsife

1.7k total citations
25 papers, 1.4k citations indexed

About

Ronna E. Dornsife is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ronna E. Dornsife has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Ronna E. Dornsife's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and Virus-based gene therapy research (5 papers). Ronna E. Dornsife is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and Virus-based gene therapy research (5 papers). Ronna E. Dornsife collaborates with scholars based in United States, China and United Kingdom. Ronna E. Dornsife's co-authors include D R Averett, Wayne H. Miller, Steven S. Good, M H St Clair, George W. Koszalka, Margaret Tisdale, N. R. Parry, John E. Reardon, Lawrence R. Boone and M B Faletto and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Ronna E. Dornsife

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronna E. Dornsife United States 16 613 559 426 412 249 25 1.4k
Kathy A. Aldern United States 20 382 0.6× 593 1.1× 312 0.7× 368 0.9× 84 0.3× 42 1.2k
Vincent J. Merluzzi United States 17 762 1.2× 452 0.8× 554 1.3× 558 1.4× 252 1.0× 32 2.2k
André Kirn France 26 755 1.2× 611 1.1× 452 1.1× 523 1.3× 291 1.2× 57 2.0k
Alonso Heredia United States 23 609 1.0× 413 0.7× 693 1.6× 320 0.8× 97 0.4× 71 1.6k
Francesca Curreli United States 19 503 0.8× 231 0.4× 415 1.0× 431 1.0× 222 0.9× 38 1.2k
Lawrence R. Boone United States 23 725 1.2× 312 0.6× 727 1.7× 643 1.6× 289 1.2× 37 1.5k
A G Tomasselli United States 14 778 1.3× 110 0.2× 739 1.7× 639 1.6× 171 0.7× 19 1.3k
Martin J. McDermott United States 21 440 0.7× 167 0.3× 309 0.7× 706 1.7× 68 0.3× 50 1.3k
Ronald B. Faanes United States 14 508 0.8× 208 0.4× 446 1.0× 442 1.1× 211 0.8× 35 1.6k
Shizuko Sei United States 26 629 1.0× 306 0.5× 574 1.3× 512 1.2× 284 1.1× 73 1.9k

Countries citing papers authored by Ronna E. Dornsife

Since Specialization
Citations

This map shows the geographic impact of Ronna E. Dornsife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronna E. Dornsife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronna E. Dornsife more than expected).

Fields of papers citing papers by Ronna E. Dornsife

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronna E. Dornsife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronna E. Dornsife. The network helps show where Ronna E. Dornsife may publish in the future.

Co-authorship network of co-authors of Ronna E. Dornsife

This figure shows the co-authorship network connecting the top 25 collaborators of Ronna E. Dornsife. A scholar is included among the top collaborators of Ronna E. Dornsife based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronna E. Dornsife. Ronna E. Dornsife is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Rui, et al.. (2021). Acute vaping exacerbates microbial pneumonia due to calcium (Ca2+) dysregulation. PLoS ONE. 16(8). e0256166–e0256166. 9 indexed citations
2.
Zhang, Rui, Ronna E. Dornsife, Tongde Wu, et al.. (2020). JUUL e-liquid exposure elicits cytoplasmic Ca2+ responses and leads to cytotoxicity in cultured airway epithelial cells. Toxicology Letters. 337. 46–56. 15 indexed citations
3.
Asquith, Christopher R. M., Tuomo Laitinen, James M. Bennett, et al.. (2017). Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase. ChemMedChem. 13(1). 48–66. 38 indexed citations
4.
Preti, Robert A., Joanne Kurtzberg, Ronna E. Dornsife, et al.. (2014). Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34+ cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers. Cytotherapy. 16(11). 1558–1574. 7 indexed citations
5.
Reap, Elizabeth A., et al.. (2007). Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191). The Journal of Immunology. 178(1_Supplement). LB40–LB40. 1 indexed citations
6.
Dev, I K, Ronna E. Dornsife, Teresa M. Hopper, et al.. (2004). Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models. British Journal of Cancer. 91(7). 1391–1398. 35 indexed citations
7.
Biron, Karen K., Richard J. Harvey, Steven S. Good, et al.. (2002). Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of Action. Antimicrobial Agents and Chemotherapy. 46(8). 2365–2372. 295 indexed citations
8.
Chan, Joseph H., Stanley D. Chamberlain, Karen K. Biron, et al.. (2000). Synthesis and Evaluation of a Series of 2′-Deoxy Analogues of The Antiviral Agent 5,6-Dichloro-2-Isopropylamino-1-(β-L-Ribofuranosyl)-1H-Benzimidazole (1263W94). Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 101–123. 7 indexed citations
9.
Joyner, S S, et al.. (1996). The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells. Antimicrobial Agents and Chemotherapy. 40(2). 331–335. 21 indexed citations
10.
11.
12.
Clair, M H St, John E. Reardon, Harvey C. Krasny, et al.. (1995). Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol. Antimicrobial Agents and Chemotherapy. 39(9). 1993–1999. 44 indexed citations
13.
Chamberlain, Stanley D., Karen K. Biron, Ronna E. Dornsife, et al.. (1994). An Enantiospecific Synthesis of the Human Cytomegalovirus Antiviral Agent [(R)-3-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic Acid. Journal of Medicinal Chemistry. 37(9). 1371–1377. 21 indexed citations
14.
Tisdale, Margaret, N. R. Parry, Ronna E. Dornsife, et al.. (1994). Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. Antimicrobial Agents and Chemotherapy. 38(4). 868–871. 49 indexed citations
15.
Morgan, Richard A., et al.. (1993). In Vitro Infection of Human Bone Marrow by Feline Leukemia Viruses. Virology. 193(1). 439–442. 9 indexed citations
16.
Gasper, Peter W., et al.. (1991). Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.. PubMed. 19(8). 759–67. 20 indexed citations
17.
Hoover, Edward A., Sandra L. Quackenbush, Mary Poss, et al.. (1990). Pathogenic mechanisms of immunodeficiency syndrome and aplastic anemia induced by feline leukemia viruses.. PubMed. 72. 163–6. 3 indexed citations
18.
Dornsife, Ronna E., Peter W. Gasper, James I. Mullins, & Edward A. Hoover. (1989). Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus. Leukemia Research. 13(9). 745–755. 19 indexed citations
19.
Riedel, N, et al.. (1988). Pathogenic and host range determinants of the feline aplastic anemia retrovirus.. Proceedings of the National Academy of Sciences. 85(8). 2758–2762. 64 indexed citations
20.
Gasper, Peter W., M. A. Thrall, David A. Wenger, et al.. (1984). Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature. 312(5993). 467–469. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy A. Aldern Breakdown of academic impact, for papers by Vincent J. Merluzzi Breakdown of academic impact, for papers by André Kirn Breakdown of academic impact, for papers by Alonso Heredia Breakdown of academic impact, for papers by Francesca Curreli Breakdown of academic impact, for papers by Lawrence R. Boone Breakdown of academic impact, for papers by A G Tomasselli Breakdown of academic impact, for papers by Martin J. McDermott Breakdown of academic impact, for papers by Ronald B. Faanes Breakdown of academic impact, for papers by Shizuko Sei
Rankless by CCL
2026